Autoimmun haarausfall

Causes of excess hair loss beyond this are diverse, ranging from hormonal, psychosomatic and autoimmune to alimentary or paraneoplastic. This article explains various .

Diagnostik und Therapie von Haar- und Kopfhauterkrankungen

1.

Cash T: The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol 1999; 141: 398–405 CrossRef

2.

Paus R, Cotsarelis G: The biology of hair follicles. N Engl J Med 1999; 341: 491–7 CrossRefMEDLINE

3.

Courtois M, Loussouarn G, Hourseau S, Grollier JF: Periodicity in the growth and shedding of hair. Br J Dermatol 1996; 134: 47–54 CrossRefCrossRef

4.

Lindner J, Hillmann K, Blume-Peytavi U, et al.: Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography. Br J Dermatol 2012; 167: 1272–8 CrossRefMEDLINE

5.

Ross EK, Vincenzi C, Tosti A: Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol 2006; 55: 799–806 CrossRefMEDLINE

6.

Whiting DA: Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 1996; 35: 899–906 CrossRef

7.

Kantor J, Kessler LJ, Brooks DG, Cotsarelis G: Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003; 121: 985–8 CrossRefMEDLINE

8.

Blume-Peytavi U, Blumeyer A, Tosti A, et al.: S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol 2011; 164: 5–15 CrossRefMEDLINE

9.

Heilmann S, Brockschmidt FF, Hillmer AM, et al.: Evidence for a polygenic contribution to androgenetic alopecia. Br J Dermatol 2013; 169: 927–30 CrossRefCrossRefMEDLINE

10.

The Finasteride Male Pattern Hair Loss Study Group: Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002; 12: 38–49 MEDLINE

11.

Blume-Peytavi U, Vogt A: Current standards in the diagnostics and therapy of hair diseases—hair consultation. J Dtsch Dermatol Ges 2011; 9: 394–410 CrossRefMEDLINE

12.

Blumeyer A, Tosti A, Messenger A, et al.: Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 2011; 9 (Suppl 6): 1–57 CrossRefMEDLINE

13.

Lucky AW, Piacquadio DJ, Ditre CM, et al.: A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 2004; 50: 541–53 CrossRefMEDLINE

14.

van Zuuren EJ, Fedorowicz Z, Carter B: Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review. Br J Dermatol 2012; 167: 995–1010 CrossRefMEDLINE

15.

Olsen EA, Dunlap FE, Funicella T, et al.: A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002; 47: 377–85 CrossRefMEDLINE

16.

Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G:
Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol 2010; 146: 1141–50 CrossRefMEDLINE

17.

Price V, Roberts JL, Hordinsky M: Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000; 43: 768–76 CrossRefMEDLINE

18.

Gubelin Harcha W, Barboza Martinez J, Tsai TF, et al.: A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol 2014; 70: 489–98 CrossRefMEDLINE

19.

Sinclair R, Wewerinke M, Jolley D: Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol 2005; 152: 466–73 CrossRefMEDLINE

20.

Freyschmidt-Paul P, Happle R, Hoffmann R: Alopecia areata. Klinik, Pathogenese und rationale Therapie einer T-Zell-vermittelten Autoimmunerkrankung. Hautarzt 2003; 54: 713–22 CrossRefMEDLINE

21.

Tosti A, Bellavista S, Iorizzo M: Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 2006; 55: 438–41 CrossRefMEDLINE

22.

Gilhar A, Etzioni A, Paus R: Alopecia areata. N Engl J Med 2012; 366: 1515–25 CrossRefMEDLINE

23.

Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M: British Association of Dermatologists’ guidelines for the management of alopecia areata 2012. Br J Dermatol 2012; 166: 916–26 CrossRefMEDLINE

24.

Tosti A, Iorizzo M, Botta GL, Milani M: Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol 2006; 20: 1243–7 CrossRefMEDLINE

25.

Fischer TW: Alopezien – Diagnostisches und therapeutisches Management. Akt Dermatol 2008; 34: 209–25 CrossRef

26.

Trüeb RM: Vernarbende Alopezien. Hautarzt 2013; 64: 810–9 CrossRefMEDLINE

27.

Powell JJ, Dawber RPR, Gatter K: Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol 1999; 140: 328–33 CrossRef

28.

Stockmeier M, Kunte C, Feldmann KA, Messer G, Wolff H: Folliculitis decalvans – Behandlung mit einer systemischen Rifampicin-Clindamycin-Kombinationstherapie bei 17 Patienten. Akt Dermatol 2001; 27: 361–3 CrossRef

29.

Bolz S, Jappe U, Hartschuh W: Successful treatment of perifolliculitis capitis abscedens et suffodiens with combined isotretinoin and dapsone. J Dtsch Dermatol Ges 2008; 6: 44–7 CrossRefMEDLINE

30.

Scerri L, Williams HC, Allen BR: Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol 1996; 134: 1105–8 CrossRefCrossRef

31.

Le Cleach L, Chosidow O: Clinical practice. Lichen planus. N Engl J Med 2012; 366: 723–32 CrossRefMEDLINE

32.

Kossard S: Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol 1994; 130: 770–4 CrossRefCrossRefMEDLINE

33.

Vano-Galvan S, Molina-Ruiz AM, Serrano-Falcon C, et al.: Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol 2014; 70: 670–8 CrossRefMEDLINE

34.

Manousaridis I, Manousaridis K, Peitsch WK, Schneider SW: Individualisierte Behandlung und Therapiewahl bei Lichen planus: ein schrittweiser Ansatz. J Dtsch Dermatol Ges 2013: 981–91 CrossRef

35.

Racz E, Gho C, Moorman PW, Noordhoek Hegt V, Neumann HA: Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review. J Eur Acad Dermatol Venereol 2013; 27: 1461–70 CrossRefMEDLINE

36.

Harries MJ, Messenger A: Treatment of frontal fibrosing alopecia and lichen planopilaris. J Eur Acad Dermatol Venereol 2014; 28: 1404–5 CrossRefMEDLINE

e1.

Sinclair R: Diffuse hair loss. Int J Dermatol 1999; 38 (Suppl 1): 8–18 CrossRefMEDLINE

e2.

Apsner R, Horl WH, Sunder-Plassmann G: Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation. Blood 2001; 97: 2914–5 CrossRef

e3.

Wilsmann-Theis D, Bieber T: Psoriasis und Ekzeme am Capillitum. Hautarzt 2014; 65: 1043–9 CrossRefMEDLINE

e4.

Trüeb RM: Systematisches Vorgehen bei Frauen mit Haaarausfall. JDDG 2010; 8: 284–98 CrossRef

e5.

Hoffmann R: TrichoScan, a GCP-validated tool to measure hair growth. J Eur Acad Dermatol Venereol 2008; 22: 132–4 CrossRefMEDLINE

e6.

Hillmer AM, Brockschmidt FF, Hanneken S, et al.: Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 2008; 40: 1279–81. CrossRefMEDLINE

e7.

Redler S, Dobson K, Drichel D, et al.: Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss. J Dermatol Sci 2013; 72: 186–8 CrossRefMEDLINE

e8.

Yim E, Nole KL, Tosti A: 5-alpha-Reductase inhibitors in androgenetic alopecia. Curr Opin Endocrinol Diabetes Obes 2014; 21: 493–8 CrossRefMEDLINE

e9.

Betz RC, Petukhova L, Ripke S, et al.: Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun 2015; 6: 5966 CrossRefMEDLINEPubMed Central

e10.

Peter C, Hoting E: Therapie der Alopecia areata mit Zinksulfat – eine placebokontrollierte Studie an 307 Patienten. Z Hautkr 1996; 71: 175–89.

e11.

Xing L, Dai Z, Jabbari A, et al.: Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med 2014; 20: 1043–9 CrossRefMEDLINEPubMed Central

e12.

Headington JT: Transverse microscopic anatomy of the human scalp. Arch Dermatol 1984; 120: 449–56 CrossRefCrossRefMEDLINE

e13.

Kunte C, Loeser C, Wolff H: Folliculitis spinulosa decalvans: successful therapy with dapsone. J Am Acad Dermatol 1998; 39: 891–3 CrossRef

e14.

Tan E, Martinka M, Ball N, Shapiro J: Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol 2004; 50: 25–32 CrossRefMEDLINE